Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;48(1):807-815.
doi: 10.1007/s11033-020-06122-x. Epub 2021 Jan 5.

The expression of Galectin-3 in breast cancer and its association with metastatic disease: a systematic review of the literature

Ioannis Boutas #  1 , Anastasios Potiris #  2 , Evangelos Makrakis  1 , Pantelis Messaropoulos  1 , Georgios-Konstantinos Papaioannou  1 , Sophia Ν Kalantaridou  1
Affiliations

The expression of Galectin-3 in breast cancer and its association with metastatic disease: a systematic review of the literature

Ioannis Boutas et al. Mol Biol Rep. 2021 Jan.

Abstract

Breast cancer is the most common form of cancer and the second highest cause of cancer mortality in female patients. The significance of the expression of Galectin-3 has been correlated with various malignancy types and in data from several research papers, the expression of Galectin-3 has been associated with the progression and metastasis of breast cancer. In the present study, the authors' goal is to identify whether the expression of Galectin-3 in breast cancer can be associated with the presence and/or recurrence of a metastatic disease. Both Scopus and PubMed databases were utilized, by inputting the following combination of keywords: (((Breast) AND Metastasis)) AND ((Galectin 3) OR Galectin-3). The time of publication and text availability were not considered when searching the databases and all relevant articles in English were initially accepted. We included one case-control study, three retrospective case studies and one retrospective cohort study. In two of the included studies, the levels in concentration of Galectin-3 were not correlated with a significant difference in prognosis. In two studies, the lacking in expression of Galectin-3 was associated with a worse prognosis and in one of the studies selected, the elevated levels of Galectin-3 were correlated with recurrence of disease in triple negative breast cancer cases. For most of the studies selected for this review, the results were contradictory in regard to the role of Galectin-3 for prognosis and metastatic potential in female breast cancer patients. It is still unclear, whether Galectin-3 can be used as a prognostic marker for advanced breast cancer disease.

Keywords: Breast cancer; Galectin-3; Metastasis; Metastatic disease; Recurrence.

PubMed Disclaimer

References

    1. Liu FT, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5(1):29–41 - DOI
    1. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T et al (1994) Galectins: a family of animal beta-galactoside-binding lectins. Cell 76(4):597–598 - DOI
    1. Takenaka Y, Fukumori T, Raz A (2002) Galectin-3 and metastasis. Glycoconj J 19(7–9):543–549 - DOI
    1. Yang RY, Liu FT (2003) Galectins in cell growth and apoptosis. Cell Mol Life Sci 60(2):267–276 - DOI
    1. Boutas I, Potiris A, Brenner W, Lebrecht A, Hasenburg A, Kalantaridou S et al (2019) The expression of galectin-3 in breast cancer and its association with chemoresistance: a systematic review of the literature. Arch Gynecol Obstet 300(5):1113–1120 - DOI

Publication types

MeSH terms

LinkOut - more resources